Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial-Reference-Cited by-同舟云学术

Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial

Published:2023-04-25 Issue:5 Volume:2 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Nagao Shoji¹,Fujiwara Keiichi¹,Yamamoto Kouji²,Tanabe Hiroshi³,Okamoto Aikou⁴,Takehara Kazuhiro⁵,Saito Motoaki⁴,Fujiwara Hiroyuki⁶,Tan David S.P.⁷⁸⁹,Yamaguchi Satoshi¹⁰,Adachi Sosuke¹¹,Kikuchi Akira¹²,Hirasawa Takeshi¹³,Yokoi Takeshi¹⁴,Nagai Tomonori¹⁵,Sato Toyomi¹⁶,Kamiura Shoji¹⁷,Fujishita Akira¹⁸,Loong Wong Wai¹⁹,Chan Karen²⁰,Syks Peter²¹,Olawaye Alexsander²²,Ryu Sang-Young²³,Shigeta Hiroyuki²⁴,Kondo Eiji²⁵,Yokoyama Yoshihito²⁶,Matsumoto Takashi²⁷,Hasegawa Kosei¹,Enomoto Takayuki¹¹

Affiliation:

1. Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka City, Japan

2. Department of Biostatistics, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan

3. Department of Obstetrics and Gynecology, The Jikei University Kashiwa Hospital, Kashiwa, Japan

4. Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo

5. Department of Gynecologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan

6. Department of Obstetrics and Gynecology, School of Medicine, Jichi Medical University, Tochigi, Japan

7. National University Cancer Institute Singapore, National University Hospital

8. Yong Loo Lin School of Medicine, National University of Singapore

9. Cancer Science Institute, National University of Singapore

10. Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi City, Hyogo, Japan

11. Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

12. Department of Gynecology, Niigata Cancer Center Hospital, Niigata, Japan

13. Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara City, Kanagawa, Japan

14. Department of Obstetrics and Gynecology, Kaizuka City Hospital, Osaka, Japan

15. Department of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

16. Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

17. Department of Gynecology, Osaka International Cancer Institute, Osaka, Japan

18. Department of Obstetrics and Gynecology, Saiseikai Nagasaki Hospital, Nagasaki, Japan

19. Department of Gynaecological Oncology, KK Women’s and Children’s Hospital, Singapore

20. Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong

21. Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand

22. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh

23. Department of Obstetrics and Gynecology, Korea Cancer Center Hospital, Seoul

24. Department of Obstetrics and Gynecology, Yokohama Municipal Citizen’s Hospital, Yokohama, Japan

25. Department of Obstetrics and Gynecology, Mie University, Tsu, Japan

26. Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan

27. Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Toon, Japan

Publisher

Massachusetts Medical Society

Reference23 articles.

1. Principles and practice of intraperitoneal chemotherapy for ovarian cancer

2. National Cancer Institute. NCI clinical announcement. Intraperitoneal chemotherapy for ovarian cancer. January 5 2006 (http://ctep.cancer.gov/highlights/docs/clin_annc_010506.pdf).

3. Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer

4. Is intraperitoneal chemotherapy still an acceptable option in primary adjuvant chemotherapy for advanced ovarian cancer?

5. Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration;Cancers;2024-08-14

2. TOPSIS Method Based on Intuitionistic Fuzzy Soft Set and Its Application to Diagnosis of Ovarian Cancer;International Journal of Computational Intelligence Systems;2024-06-24

3. The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy;Frontiers in Oncology;2024-06-10

4. Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models;International Journal of Clinical Oncology;2024-05-20

5. Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer;The Obstetrician & Gynaecologist;2024-03-15